Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02853331 |
|---|---|
| Brief Title: | Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426) |
| First Submitted : | July 29, 2016 |
| First Submitted that Met QC Criteria : | July 29, 2016 |
| First Posted : | August 2, 2016 (Estimate) |
| Results First Submitted : | October 18, 2019 |
| Results First Submitted that Met QC Criteria : | October 18, 2019 |
| Results First Posted : | November 8, 2019 |
| Last Update Submitted that Met QC Criteria : | March 4, 2024 |
| Last Update Posted : | March 7, 2024 |